Here, we report LRP5 plays a vital oncogenic role in CRC development and contributes to the chemoresistance of CRC cells, partially through activating the canonical Wnt/β‐catenin and IL‐6/STAT3 signalling pathways and consequently promoting CSCs phenotypes. The gene discussed is LRP5; the disease is colorectal carcinoma.